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a b s t r a c t 
It has been suggested that several dietary compounds may improve endothelial dysfunction and oxidative
stress induced by smoking. We investigated the effects of acute smoking on blood pressure, heart rate
(HR), peripheral arterial function (reactive hyperemia index, RHI), and arterial stiffness in young smokers
by Endo-PAT2000. Twenty subjects that smoked an average of 15 cigarettes per day participated in the
study. Reactive Hyperemia Index, arterial stiffness, blood pressure and HR were assessed before and after
smoking one cigarette. Acute smoking significantly reduced RHI by 28% while increased arterial systolic
( + 14%) and diastolic ( + 10%) blood pressure and HR ( + 13%) at 5 min, while no effect was observed after 30
min. Arterial stiffness was not significantly affected. A significant, positive correlation was found between
total serum cholesterol concentration and post-smoking arterial stiffness values. This study demonstrates
that acute cigarette smoking impairs RHI and vital signs in young moderate smokers as evaluated through a
non-invasive technique. Additionally, the experimental model described, where a decrease of RHI is induced
by cigarette smoking, may be useful to study the impact of dietary vasoactive compounds on endothelial
function. 
c © 2013 Published by Elsevier B.V. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
Recently, the study of the effect of diet in the modulation of oxida-
tive stress-related processes in vivo is under investigation. Cigarette
smoking is one condition that increases oxidative stress but also im-
pairs endothelial function [ 1 , 2 ]. Endothelial dysfunction is described
as the inability of the artery to sufficiently dilate in response to an ap-
propriate stimulus and is considered an early phenomenon in athero-
genesis [ 3 ]. This condition has been widely described in coronary and
brachial arteries of healthy chronic moderate smokers and more of-
ten in passive smokers. The mechanism of endothelial dysfunction
through smoking is poorly understood, but it seems to be attributed
to the known / unknown substances (i.e. reactive oxygen and nitrogen
species, nicotine, benzopyrene and acrolein) that constitute the par-
ticulate (tar) and gaseous phase of the cigarette [ 4 ]. These componentsAbbreviations: BMI, body mass index; dAix, digital augmentation index; dAix@75, 
digital augmentation index standardized for heart rate of 75 bpm; DiBP, diastolic blood 
pressure; FMD, flow mediated dilation; HDL-C, high density lipoprotein-cholesterol; 
HR, heart rate; LDL-C, low density lipoprotein-cholesterol; NO, nitric oxide; PAT, pe- 
ripheral arterial tone; RHI, reactive hyperemia index; SyBP, systolic blood pressure; 
TG, triglycerides; TSC, total serum cholesterol. 
* Corresponding author at: Department of Food, Environmental and Nutritional Sci- 
ences (DeFENS), Division of Human Nutrition - Universit `a degli Studi di Milano, Via G. 
Celoria 2, 20133 Milano, Italy. Tel.: + 39 02 50316726; fax: + 39 02 50316721. 
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2213-4344/ $ - see front matter c © 2013 Published by Elsevier B.V. 
http://dx.doi.org/10.1016/j.phanu.2013.07.001 may induce oxidative stress and inflammation with detrimental con-
sequences on endothelial function. The increase in free radical species
may reduce the production and bioavailability of nitric oxide (NO), the
most important vasodilator produced by endothelial cells, with anti-
atherosclerotic and anti-proliferative function [ 3 ]. Cigarette smoking
may also participate in the uncoupling of endothelium-derived nitric
oxide synthase, subsequently attenuating NO production and increas-
ing superoxide generation [ 5 ]. 
The deleterious effects of cigarette smoking also involve an in-
crease in arterial wall stiffness, one of the underlying pathophysio-
logical mechanisms of the cardiovascular process [ 6 ]. Arterial stiff-
ness has been related to the Framingham and other cardiovascular
risk scores and it is considered a predictor of cardiovascular events in
the general population, in patients with hypertension, end-stage re-
nal disease, impaired glucose intolerance, and coronary artery disease
[ 7 ]. Measurement of arterial stiffness provides information about the
functional and structural vascular changes at the level of the aorta,
muscular conduit arteries, peripheral branches, and microvascular
components [ 7 ]. In this regard, the augmentation index (Aix) is widely
used as a surrogate measure of arterial stiffness and a composite index
of arterial dysfunction [ 8 ]. 
A noninvasive plethysmographic method (Endo-PAT2000) able to
measure peripheral vasodilator response (RHI) and digital arterial
stiffness (dAix) has been recently validated [ 9 ]. This method provides
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c measurement of peripheral arterial tone (PAT) after a hyperemia- 
nduced protocol. Compared to other most popular and noninvasive 
echniques that use flow-mediated dilation (FMD) value to assess en- 
othelial dysfunction [ 10 ] such as brachial artery ultrasound, Endo- 
AT has several advantages. It provides reliable and reproducible 
esults, is user independent, and records systemic changes on the 
ontra-lateral arm, resulting in an internal control system. 
The effects of smoking on peripheral arterial function and digi- 
al arterial stiffness assessed by the Endo-PAT2000 device have not 
een thoroughly investigated and results are still inconclusive [ 11 –
3 ]. Moreover, this device has been proposed as a tool in evaluating 
he effect of a single or long term exposure to foods / bioactive com- 
ounds on arterial function with conflicting results. This may depend 
n subject characteristics such as age, sex, dietary and life-style habits, 
hysical activity, but also on the specific experimental protocol used. 
Based on results obtained in a previous study [ 14 ] where we 
ailed to demonstrate a significant modulation of endothelial func- 
ion (evaluated through EndoPAT-2000) following regular intake of 
n anthocyanin-rich product in subjects with different risk factors 
or cardiovascular disease, we embarked on utilizing smoking as a 
tressor to develop a model that may better demonstrate the effect 
f dietary vasoactive compounds. The aim of the present study is to 
valuate whether peripheral arterial tone (PAT) technology is able to 
etect the acute effects of a single cigarette smoking on RHI and dAix 
n a homogeneous group of young healthy male smokers. If PAT tech- 
ology is able to detect the acute effects of smoking a single cigarette 
n peripheral arterial function, then this model could be applied for 
tudying the impact of dietary bioactive compounds in the modula- 
ion of endothelial function administered before smoking. 
. Materials and methods 
.1. Subject recruitment 
In order to select a homogeneous group of healthy smokers vol- 
nteers, twenty males, 23.6 ± 2.9 average age with body mass index 
BMI) of 22.4 ± 2.2 kg / m 2 , were recruited from the student popula- 
ion of the University of Milan according to the following criteria: 20–
0 years of age, moderate smoking (about 15 cigarette / day; smoking 
rom at least 5 years), moderate physical activity (25–30 min per day 
f brisk walk or jog) and moderate alcohol consumption (up to 10–14 
rinks per week). Subjects were selected on the basis of an inter- 
iew by a dietitian to evaluate their dietary habits. Exclusion criteria 
ere as follows: hypertension (systolic blood pressure > 140 mm Hg 
nd / or diastolic blood pressure > 90 mm Hg), hyperglycemia ( > 10 
mol / L), hypertriglyceridemia (TG ≥1.69 mmol / L) and hypercholes- 
erolemia [total serum cholesterol (TSC) ≥5.17 mmol / L, low high- 
ensity lipoprotein (HDL) cholesterol (C) < 1.03 mmol / L, high low 
ensity lipoprotein (LDL) cholesterol (C) ≥3.36 mmol / L], and over- 
eight (BMI ≥ 25 kg / m 2 ). Endothelial dysfunction (RHI < 1.67) was 
nother important exclusion criterion. Subjects declared no history 
f cardiovascular, coronary, diabetes, hepatic, renal, or gastrointesti- 
al diseases, anemia, chronic asthma, allergy, traumas of the arms 
r hand, fingers, atopic dermatitis, thyroid disturbance, depression, 
nxiety, palpitations and chronic backache. Moreover, subjects were 
xcluded if they were taking any supplement, drug, or medication 
or at least one month before the beginning of the study. The study 
as approved by the Ethics Committee of the University of Milan. All 
articipants gave informed consent and the study was in accordance 
ith the Declaration of Helsinki. 
.2. Experimental design 
Subjects were asked to avoid foods containing substances with 
ossible vasoactive properties 10 days before experimentation. Spe- 
ific attention was devoted to foods such as chocolate, berry fruits (i.e. blueberries, cranberries, raspberries, blackcurrants and elderber- 
ries), red wine and red / violet fruits, green tea. All participants were 
asked to refrain from physical activity from the day before the ex- 
periment and to smoke the number of cigarettes / day declared in the 
questionnaire (i.e. about 15 cigarettes per day). The day before the 
experiments and during the trial, breakfast, lunch and dinner were 
standardized. The standardized dinner was consumed by 9.00 pm and 
only one coffee was permitted with a maximum of two coffees during 
the day. Moreover alcoholic drinks or soft drinks were not allowed. 
With regard to the establishment of the peripheral arterial func- 
tion evaluation protocol, we chose to avoid multiple measurements 
(involving 5 min arterial occlusion through cuff inflation) in a short 
time-period, because it could promote vasodilatation through NO pro- 
duction between test and re-test measurements [ 15 ]. Thus, peripheral 
arterial function was measured in two consecutive days. Moreover, 
we pre-tested the protocol [ 16 ] to exclude an inter-day variability and 
to assure a within-subject repeatability of basal levels of RHI as also 
reported by other authors [ 17 , 18 ]. For the present study, overnight 
fasted volunteers came to our laboratory early in the morning; base- 
line levels were assessed the first day, while the second day RHI was 
evaluated 20 min after smoking a single cigarette (containing approx- 
imately 8 mg of Tar by volume, 0.6 mg of nicotine and 9 mg of carbon 
monoxide) in a smoking room close to the test room. Systolic blood 
pressure (SyBP), diastolic blood pressure (DiPB) and HR were mea- 
sured before and 5 min after smoking and at the end of the evaluation 
of peripheral vasoreactivity (30 min after smoking). The study design 
is reported in Fig. 1 . 
2.3. Peripheral arterial function and arterial stiffness 
Endothelial-dependent vasodilation in the small finger arteries 
was assessed by a non-invasive plethysmographic method (Endo- 
PAT2000, Itamar Medical Ltd., Caesarea, Israel) based on the regis- 
tration of pulsatile blood volume in the fingertips of both hands. The 
Endo-PAT system consists of two finger-mounted probes, composed 
of inflatable latex air-cushions within a rigid external case; pulsatile 
volume changes of the fingertip are sensed by a pressure transducer, 
located at the end of each probe and transferred to a personal com- 
puter where the signal is band pass-filtered (0.3–30 Hz), amplified, 
displayed, and stored. A blood pressure cuff was placed on one upper 
arm (study arm), while the contralateral arm served as a control (con- 
trol arm). After a 10-min equilibration period, the blood pressure cuff 
on the study arm was inflated to 60 mm Hg above systolic pressure 
for 5 min. The cuff was then deflated to induce reactive hyperemia 
whereas the signal from both PAT channels (Probe 1 and Probe 2) was 
recorded by a computer. The RHI, an index of the FMD, was derived 
automatically in an operator independent manner, as the ratio of the 
average pulse wave amplitude during hyperemia (60–120 s of the 
post-occlusion period) to the average pulse wave amplitude during 
baseline in the occluded hand, divided by the same value in the con- 
trol hand and then multiplied by a baseline correction factor. A RHI 
value of 1.67 provides a sensitivity of 82% and a specificity of 77% in 
diagnosing endothelial dysfunction [ 19 ]. 
The EndoPAT device also generates dAix, strongly correlated to 
aortic Aix, calculated from the shape of the pulse wave recorded by 
the probes during baseline [ 20 ]. Because dAix is influenced in an 
inverse and linear manner by heart rate, the dAix was automatically 
normalized by the tool for a heart rate of 75 bpm (dAix@75). 
2.4. Analysis of biochemical parameters 
Twelve out of the twenty volunteers recruited, gave their consent 
to provide a blood sample for biochemical analysis. Data obtained 
were used to test the relationship between parameters of nutritional 
status and arterial function measurements. 
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Fig. 1. Experimental design. BP, blood pressure; HR, heart rate; RHI, reactive hyperemia index; dAix, digital augmentation index; dAix@75, digital augmentation index standardized 
for heart rate of 75 bpm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 
Anthropometric and clinical characteristics of the subjects at baseline ( n = 20) a . 
Variables Value 
Age (years) 23.6 ± 2.9 
Height (cm) 177.2 ± 6.7 
Weight (kg) 70.6 ± 9.9 
BMI (kg / m 2 ) 22.4 ± 2.2 
Neck circumference (cm) 36.2 ± 1.4 
Shoulder circumference (cm) 109.5 ± 5.1 
Chest circumference (cm) 94.2 ± 6.3 
Waistline circumference (cm) 78.2 ± 6.2 
Abdominal circumference (cm) 83.0 ± 5.9 
Hip circumference (cm) 95.5 ± 6.3 
Arm circumference (cm) 27.6 ± 2.4 
Forearm circumference (cm) 25.7 ± 1.8 
Wrist circumference (cm) 17.0 ± 0.6 
Smoking (cigarettes / day) 15 ± 2 
SyBP (mm Hg) 114.4 ± 7.9 
DiBP (mm Hg) 72.2 ± 6.3 
HR (beat / min) 57.9 ± 7.6 
RHI 2.23 ± 0.28 
dAix (%) −8.6 ± 8.0 
dAix@75 (%) −18.4 ± 8.9 
a Data are expressed as means ± SD (standard deviation). BMI, body mass index; SyBP, 
systolic blood pressure; DiBP, diastolic blood pressure; HR, heart rate; RHI, reactive 
hyperemia index; dAix, digital augmentation index; dAix@75, digital augmentation 
index standardized for heart rate of 75 bpm. 
 
 
 
 
 
 
 
 
 Blood was collected early in the morning by a phlebotomist. Sam-
ples were drawn into evacuated tubes without heparin. Serum was
separated within 1 h, by centrifugation for 15 min at 2300 × g at 4
◦C. Analysis of lipid profile (triglycerides, total cholesterol, and HDL-
cholesterol), glucose, vitamin B 12 and total folate was performed us-
ing a cobas 
®
6000 analyzer series (Roche Diagnostics, North Amer-
ica). Low Density Lipoprotein cholesterol (LDL-C) was calculated using
the Friedewald’s equation. 
2.5. Statistical analysis 
Sample size was calculated according to the expected variation in
the primary endpoint considered (RHI). In particular, twenty subjects
was calculated to be sufficient to evaluate a difference of RHI after
smoking of 0.28 (standard deviation 0.40), with alpha = 0.05 and a
statistical power of 80%. Statistical analysis was carried out with the
Statistical Package for the Social Sciences (SPSS inc., Chicago, IL, U.S.)
release 17.0 for Windows. Pre and post-smoking differences were
tested by paired Student’s t -test while ANOVA with repeated mea-
sures, followed by the Bonferroni test for multiple comparisons, was
used to assess the variation over time of SyBP, DiBPand HR. The rela-
tionship among different variables was determined using the Pearson
correlation test. The level of significance was set at P ≤ 0.05. Data are
presented as mean and standard deviation. 
3. Results 
3.1. Baseline characteristics of the study population 
The baseline clinical and anthropometric characteristics of the en-
rolled volunteers are reported in Table 1 . Subjects presented normal
vital signs (SyBP / DiBP < 140 / 90 mm Hg) and endothelial function
(RHI > 1.67) consistent with their young age. 
3.2. Effect of smoking on blood pressure and heart rate 
Fig. 2 shows the values of blood pressure and heart rate before
and after smoking. Repeated measures ANOVA analysis, revealed a
significant variation over time ( P < 0.001) of SyBP, DiBP and HR; inparticular all parameters assessed 5 min after smoking were signifi-
cantly higher with respect to baseline and after RHI. The mean percent
change pre-to post smoking was + 13.8% (95%CI: + 11.4%, + 16.2%)
for SyBP, + 10.2% (95%CI: + 6.4%, + 14%) for DiBP and + 12.8% (95%
CI: + 6.2%, + 19.4%) for HR. This effect was transient and the values
fell to baseline after 30 min. 
3.3. Effect of smoking on arterial function and digital augmentation 
index 
Table 2 reports the values of RHI, dAix and dAix@75 before and
after smoking. Peripheral arterial function was impaired 20 min after
cigarette smoking. The mean percentage change pre-to post smoking
was −27.6% (95%CI: −35.2%, −20.1%). The RHI reduction was observed
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Fig. 2. Variation of systolic and diastolic blood pressure (1A), and heart rate (1B) in 
the overall population over time. SyBP, systolic blood pressure; DiBP, diastolic blood 
pressure; HR, heart rate. *Data are not significantly different. 
Table 2 
Arterial function and arterial stiffness before and 20 min after smoking a cigarette in 
the overall population a . 
Before smoking 
20 min After 
smoking P value b 
RHI 2.23 ± 0.28 1.59 ± 0.27 0.0001 
dAix (%) −8.6 ± 8.0 −13.1 ± 7.5 0.007 
dAix@75 (%) −18.4 ± 8.9 −18.0 ± 8.9 0.785 
a N = 20. Data are expressed as means ± SD. RHI, reactive hyperemia index; dAix, digital 
augmentation index; dAix@75, digital augmentation index standardized for heart rate 
of 75 bpm. 
b Overall P value for t -TEST with Statistical Package for the Social Sciences (SPSS Inc., 
Chicago, IL, U.S.). 
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sn all subjects and was particularly high insomuch as to induce en- 
othelial dysfunction (RHI < 1.67) in more than a half of the subjects 
13 out of 20). 
Regarding dAix, a significant reduction was also observed ( Table 
 ), while no significant effect was detected after normalization for 
eart rate (dAix@75). 
The correlation among endothelial function variables and vital 
igns in the overall population is presented in Table 3 . As shown, 
ndothelial function was not correlated with blood pressure values, 
R and dAix and dAix@75. Only baseline dAix@75 and post-smoking 
Aix@75 variables correlated with pre-smoking HR ( R = 0.503; P = 
.024) and with both pre-smoking ( R = 0.593; P = 0.006) and post- 
moking ( R = 0.496; P = 0.026) HR levels, respectively. 3.4. Relationship between basal levels of biochemical parameters and 
arterial function in a sub-group of subjects 
Data on lipid profile (total, HDL and LDL cholesterol, and triglyc- 
erides), glycaemia (fasting blood glucose) and vitamin status (folate 
and vitamin B 12 ) measured at baseline in the group of 12 subjects are 
reported in Table 4 . All these parameters were within the range of 
normality. 
The results of t -test comparison between pre- and post-smoking 
RHI, dAix, dAix@75, SyBP, DiBP and HR in this subgroup were similar 
to those obtained in the total 20 subjects, as well as the correlations 
between endothelial function and vital signs ( Tables 5-7 ). A positive 
correlation was found between total serum cholesterol concentra- 
tions and post-smoking Aix@75 values ( Table 8 ). 
4. Discussion 
In the present study we documented that cigarette smoking 
acutely increases arterial blood pressure and heart rate and reduces 
peripheral endothelial function in the distal arterial system, assessed 
by Endo-PAT technology, in healthy young smokers. 
The regulation of small peripheral arteries is of paramount impor- 
tance because these vessels determine peripheral vascular resistance 
and organ blood supply; therefore they are of interest in clinical prac- 
tice. Moreover, endothelial dysfunction exists not only in conduit 
arteries, but also extends to the more distal arterial system. Sev- 
eral investigators have studied the FMD changes in macrovascular 
beds (coronary, carotid and brachial arteries) of active and passive 
cigarette smokers [ 21 , 22 ] while only little and inconclusive informa- 
tion is available on the effect of smoking on endothelial-dependent 
response of peripheral vascular arteries. Bonetti et al. documented 
that a single 1 h exposure to passive smoking, led to deterioration of 
digital microvascular endothelial function in non-smoker volunteers 
[ 23 ]. Xue et al. [ 13 ] found a significant reduction in peripheral arte- 
rial function, 20 min after smoking, while no effect was observed by 
Moerland et al. at 30 and 90 min after smoking [ 11 ]. The divergence 
between brachial and digital vascular function emphasizes the pos- 
sibility that vasodilation may vary significantly with vessel size and 
location [ 9 ]. Vessels and microvessels of different diameters exhibit 
different sensitivity to vasoactive stimuli [ 24 ]. Moreover, it is widely 
recognized that gender, age and physical activity may strongly influ- 
ence endothelial function [ 25 ]. 
In this study, we tried to standardize the protocol through a se- 
lection of a homogeneous population for gender, age, smoking habits, 
alcohol consumption, dietary habits, physical activity and anthropo- 
metric characteristics, and we documented that acute smoking in- 
duces peripheral arterial dysfunction in young male smokers. The 
mechanism responsible of the microvascular dysfunction is not clear, 
but a role of nicotine and other atherogenic compounds may be pro- 
posed. Nicotine and free radicals (i.e. superoxide anion and hydroxyl 
radicals) may injure the endothelium and reduce the production of 
NO [ 21 ]. Moreover, smoking elevates the circulating levels of poten- 
tial blood vessel vasoconstrictor agents such as endothelin-1 and cat- 
echolamines that seem to increase immediately after smoking and in- 
duce hypertension and endothelial dysfunction [ 26 , 27 ]. Several stud- 
ies suggest that impaired microvascular function contributes to an 
increase in blood pressure and heart rate [ 26 ]. We documented that 
short-term smoking increased blood pressure and heart rate and these 
changes occurred 5 min after smoking and were not apparent 30 min 
later. 
In contrast, from data previously reported [ 28 ], we observed a 
trend toward a decrease of dAix after smoking. However, because 
heart rate has been shown to be a possible confounder in the de- 
termination of dAix, no effect was observed after normalization for 
heart rate (dAix@75) [ 29 ]. This could be attributed to the young age of 
smokers having a better compensatory response to an injury [ 30 , 31 ]. 
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Table 3 
Correlation coefficients among endothelial function variables and vital signs in the overall population. 
N = 20 SyBP B DiBP B HR B SyBP S DiBP S HR S 
RHI B R .255 −.033 .315 .063 −.259 .411 
P value .278 .889 .176 .792 .270 .072 
RHI S R .012 .007 −.156 .079 .309 .127 
P value .960 .976 .513 .742 .185 .592 
dAix B R −.349 −.094 .156 −.110 −.174 −.149 
P value .132 .693 .513 .643 .463 .531 
dAix S R −.370 −.065 −.019 .045 −.066 −.274 
P value .108 .785 .935 .850 .784 .242 
dAix@75 B R −.072 .259 .503 .088 .092 .230 
P value .762 .270 .024 * .712 .699 .329 
dAix@75 S R −.146 .326 .593 .125 .183 .496 
P value .539 .161 .006 * .600 .440 .026 * 
B, baseline; S, after smoking; RHI, reactive hyperemia index; dAix, digital augmentation index; dAix@75, digital augmentation index standardized for heart rate of 75 bpm; SyBP, 
systolic blood pressure; DiBP, diastolic blood pressure; HR, heart rate. R , correlation coefficient. 
∗Correlation is statistically significant. 
Table 4 
Baseline biochemical parameters in a sub-sample a . 
Variables Value 
Total cholesterol (mmol / L) 4.16 ± 0.54 
LDL-cholesterol (mmol / L) 1.5 ± 0.34 
HDL-cholesterol (mmol / L) 2.17 ± 0.41 
Triglycerides (mmol / L) 1.04 ± 0.42 
Fasting glucose (mmol / L) 3.89 ± 0.67 
Folate (ng / mL) 6.4 ± 1.9 
Vitamin B 12 (pg / mL) 403 ± 105 
LDL, low density lipoprotein; HDL, high density lipoprotein. 
a N = 12. Data are expressed as means ± SD. 
Table 5 
Arterial function and arterial stiffness before and 20 min after smoking a cigarette in a 
sub-sample a . 
Before smoking 
20 min after 
smoking P value b 
RHI 2 .23 ± 0.26 1 .59 ± 0.30 0 .0001 
dAix (%) −7 .6 ± 7.5 −12 .5 ± 6.1 0 .009 
dAix@75 (%) −18 .9 ± 8.9 −17 .7 ± 9.6 0 .480 
a N = 12. Data are expressed as means ± SD. RHI, reactive hyperemia index; dAix, digital 
augmentation index; dAix@75, digital augmentation index standardized for heart rate 
of 75 bpm. 
b Overall P value for t -TEST with Statistical Package for the Social Sciences (SPSS Inc., 
Chicago, IL, U.S.). 
Table 6 
Variation of systolic and diastolic blood pressure and heart rate in a sub-sample over 
time 1 . 
Time 0 min Time 5 min Time 30 min P value 2 
SyBP 115.6 ± 7.7 a 132.1 ± 6.9 b 117.1 ± 5.6 a < 0.001 
DiBP 75.7 ± 7.2 a 81.9 ± 8.9 b 77.0 ± 6.4 a < 0.001 
HR 63.0 ± 13.4 a 70.7 ± 13.2 b 63.4 ± 13.0 a < 0.001 
a,b Data with different letters in the same row are significantly different. 
1 N = 12. Data are expressed as means ± SD. SyBP, systolic blood pressure; DiPB, 
diastolic blood pressure; HR, heart rate. 
2 Overall P value for t -TEST with Statistical Package for the Social Sciences (SPSS inc., 
Chicago, IL, U.S.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  However, a significant positive correlation was observed between
dAix@75 and HR, and dAix@75 after smoking and HR pre-post smok-
ing, indicating that cardiac frequency is enhanced by increasing vessel
stiffness. 
Diet and nutritional status can affect endothelial function and ar-
terial stiffness. It is widely recognized that high circulating levels of
triglycerides and cholesterol are associated with endothelial dysfunc-
tion and impairment of arterial stiffness in the brachial artery [ 32 ].
However, the association in the small and distal arteries is not well un-
derstood. In the present study, no correlation was observed between
serum cholesterol and RHI, and dAix@75 at baseline, while a positive
and interesting correlation was observed between total serum choles-
terol levels at baseline and the levels of dAix@75 after smoking. This
may suggest that people with high serum cholesterol levels exhibit
a higher vessel stiffness following smoking. To our knowledge, this
is the first study to document an association between serum choles-
terol levels and the augmentation index in small and distal peripheral
arteries. This is an important finding not only in underlying the role
of cholesterol for arterial function even in young individuals, but also
suggesting that lipid profile characterization may be useful when con-
sidering subjects enrolled in studies on endothelial function. 
5. Conclusions 
In conclusion, acute cigarette smoking increased arterial blood
pressure and heart rate and reduced peripheral arterial function, mea-
sured by peripheral arterial tonometry, in young moderate smokers.
Additionally, this is the first study to show a correlation between
serum cholesterol levels and digital augmentation index in small and
distal peripheral arteries; thus, further studies with larger sample size
are recommended to explore this relationship. 
The experimental model described here, where a decrease of RHI
is easily induced by cigarette smoking, could be useful in studying the
impact of dietary vasoactive compounds such as anthocyanins (pre-
viously tested in our long term study) [ 14 ] in modulating peripheral
arterial function. It has been recently argued that the relationship be-
tween food and “pharma” is not well-defined and sometimes it may
overlap. Several bioactive compounds, including polyphenols, may
significantly contribute to optimal health and prevention of several
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Table 7 
Correlation among endothelial function variables and vital signs in a sub-sample. 
N = 12 SyBP B DiBP B HR B SyBP S DiBP S HR S 
RHI B R .017 −.293 .409 .003 −.337 .560 
P value .957 .355 .187 .993 .284 .058 
RHI S R −.078 .174 −.074 .007 .435 .171 
P value .809 .589 .819 .982 .158 .595 
dAix B R −.587 −.190 .313 −.074 −.082 .069 
P value .045 * . 554 .322 .819 .799 .832 
dAix S R −.531 −.147 −.112 .087 .072 −.135 
P value .076 . 648 .729 .787 .823 .676 
dAix@75 B R −.457 .030 .409 .045 .042 .355 
P value .136 .927 .187 .890 .898 .258 
dAix@75 S R −.323 .151 .597 .066 .167 .689 
P value .305 .640 .040 * .838 .604 .013 * 
B, baseline; S, after smoking; RHI, reactive hyperemia index; dAix, digital augmentation index; dAix@75, digital augmentation index standardized for heart rate of 75 bpm; SyBP, 
systolic blood pressure; DiBP, diastolic blood pressure; HR, heart rate; R, correlation coefficient. 
∗Correlation is statistically significant. 
Table 8 
Correlation coefficients among endothelial function variables and baseline biochemical parameters in a sub-sample. 
N = 12 CHOL B HDL-C B LDL-C B TG B GLC B VitB 12 B Folate B 
RHI B R .125 −.532 .397 .391 −.208 −.074 −.145 
P value .714 .092 .226 .235 .540 .830 .672 
RHI S R −.213 −.037 −.222 −.074 −.483 −.225 −.328 
P value .529 .914 .513 .829 .132 .506 .324 
dAix B R .190 .408 .020 −.200 −.149 .203 .406 
P value .577 .213 .953 .555 .662 .549 .215 
dAix S R .307 .521 −.022 .033 −.391 −.093 .058 
P value .359 .101 .949 .924 .234 .786 .865 
dAix@75 B R .488 .332 .341 .071 −.260 .398 .409 
P value .128 .319 .305 .836 .440 .225 .211 
dAix@75 S R .681 .360 .466 .290 −.063 .429 .394 
P value .021 * .276 .148 .388 .855 .188 .230 
B, baseline; S, after smoking; RHI, reactive hyperemia index; Aix, augmentation index, Aix@75 standardized for heart rate of 75 bpm; CHOL, total serum cholesterol; HDL-C, high 
density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglycerides; GLC, glycaemia; R , correlation coefficient. 
∗Correlation is statistically significant. 
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mhronic diseases [ 33 ]. Thus, it is important to demonstrate the effec- 
iveness of foods and / or constituents in the modulation of specific 
unctions through experimental designs that are typical of pharma- 
ological approaches [ 33 ]. 
ayperson’s summary 
There is specific interest in dietary strategies able to counteract 
xidative stress induced phenomena; however, the study of such an 
nteraction is not easy and results depend on the experimental de- 
ign, stressors and biomarkers used to evaluate the effects. In this 
egard, cigarette smoking increases oxidative stress but also induces 
ndothelial dysfunction; an early phenomenon in atherogenesis. The 
echanism of endothelial dysfunction induced by smoking seems to be related to several substances constituting the particulate (tar) 
and gaseous phase of cigarettes. Smoking is able to induce oxida- 
tive stress / damage and inflammation and also the production and 
bioavailability of nitric oxide (the most important vasodilatory agent) 
produced by endothelial cells. Moreover, smoking involves an in- 
crease in arterial wall stiffness, one of the underlying pathophysio- 
logical mechanisms of the cardiovascular process. Recently, a non- 
invasive plethysmographic method (Endo-PAT2000) able to measure 
endothelial function and arterial stiffness has been validated, but its 
application to study the effect of smoking has not been thoroughly in- 
vestigated. In addition, this device has been proposed to evaluate the 
effect of single or long term exposures to foods / bioactive compounds 
on improving of endothelial function with conflicting results. This 
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 may depend on subject characteristics but also on the specific exper-
imental protocol implemented. The present study evaluates whether
PAT technology can be exploited to detect the acute effects of smok-
ing a single cigarette in a homogeneous group of young, healthy, male
smokers. To this aim, endothelial function and arterial stiffness are as-
sessed before and 20 min after smoking. If results confirm the ability
of PAT technology to measure changes in endothelial function with
smoking, it may be applied for studying the impact of dietary bioac-
tive compounds, administered before smoking on the modulation of
endothelial function. 
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